Popular Articles

SOS Research Project Assesses The Cardiovascular And Gastrointestinal Risk Related To The Use Of Non-steroidal Anti-inflammatory Drugs (NSAIDs)
Medical information of more than 35 million persons from the general European population will be studied with the goal of better guiding clinicians how to balance the risk of gastrointestinal and cardiovascular events when prescribing NSAIDs.

Labs Are Vital™ Announces Winners Of 2009 National Video Contest To Highlight Careers In Lab Sciences
Labs Are Vital™ announced that a 2009 high school graduate from northern California, Kelly Peterson, is the grand prize winner of its national video contest. High school students around the country submitted their views on video about why careers in the clinical lab sciences are vital.
News of the day
Factors Affecting Benefit/Harm Of Intensive Glucose Control In Type 2 Diabetes Reported
Factors affecting whether intensive glucose control is likely to reduce or increase the risk of cardiovascular events, including death, based on evidence in the VA Diabetes Trial, were reported in a symposium here today at the American Diabetes Association"s 69th Scientific Sessions.
Medical Devices

GE, Big Vendors Corner EMR Market; Smaller Vendors Explore Health 2.0

Staying ahead of the upcoming drive to sell electronic health records to hospitals and physicians may be difficult for smaller vendors, Pharmawire/Financial Times reports. General Electric announced a program last week to provide health care organizations with financing options to purchase health technology through its financial services arm even as it sells electronic records through its health care wing. Other large vendors like Cerner and McKesson will be able to keep up, but smaller producers will be left behind, industry experts said. A rush of new customers is expected in upcoming years because the American Recovery and Reinvestment Act provides incentives - more than $20 billion - for health providers to purchase the technology (Avallone and Longpre, 6/24). In other news, Atlas Venture, a venture capital firm, is gearing up to make investments that will "improve health care by empowering patients," the Wall Street Journal"s blog, Venture Capital Dispatch, reports. The company has recently invested in Keas, a health 2.0 company that develops Web technologies that help consumers "better their health." Atlas partner and technology specialist Jeff Fagnan said "the firm may make four or five of these types of investments with its current fund... which closed at $283 million last year" (Gormley, 6/25). This information was reprinted from kaiserhealthnews.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Health Policy Report, search the archives and sign up for email delivery at kaiserhealthnews.org. © Henry J. Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):